Abstract
A combination of the general anesthestic propofol and epidural anesthesia with a local anesthetic is widely used. The metabolism of ropivacaine and that of lidocaine are mediated by similar P450 isoforms. Previously, propofol was found to inhibit the metabolism of lidocaine in vitro. Here we investigated whether propofol inhibits the metabolism of ropivacaine using human liver microsomes in vitro. Ropivacaine (6.0 µmol·l−1) as the substrate and propofol (1–100 µmol·l−1) were reacted together using human microsomes. The concentrations of ropivacaine and its major metabolite 2′,6′-pipecoloxylidide (PPX) were measured using high-performance liquid chromatography. The metabolic activity of ropivacaine was reflected in the production of PPX. The inhibitory effects of propofol on ropivacaine metabolism were observed to be dose-dependent. The IC50 of propofol was 34.9 µmol·l−1. Propofol shows a competitive inhibitory effect on the metabolism of ropivacaine (i.e., PPX production mediated by CYP3A4) in human CYP systems in vitro.
Similar content being viewed by others
References
TL Chen TH Ueng SH Chen PH Lee SZ Fan CC Liu (1995) ArticleTitleHuman cytochrome P450 mono-oxygenase system is suppressed by propofol Br J Anaesth 74 558–562 Occurrence Handle1:STN:280:ByqB1M%2FjtV0%3D Occurrence Handle7772432
C Lejus A Fautrel Y Mallédant A Guillouzo (2002) ArticleTitleInhibition of cytochrome P450 2E1 by propofol in human and porcine liver microsomes Biochem Pharmacol 64 1151–1156 Occurrence Handle10.1016/S0006-2952(02)01226-1 Occurrence Handle1:CAS:528:DC%2BD38XntVWqsb0%3D Occurrence Handle12234619
J Gemayel A Geloen F Mion (2001) ArticleTitlePropofol-induced cytochrome P450 inhibition: an in vitro and in vivo study in rats Life Sci 68 2957–2965 Occurrence Handle10.1016/S0024-3205(01)01091-8 Occurrence Handle1:CAS:528:DC%2BD3MXjvFaqsb8%3D Occurrence Handle11411795
N Hamaoka Y Oda I Hase K Mizutani T Nakamoto T Ishizaki A Asada (1999) ArticleTitlePropofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study Clin Pharmacol Ther 66 110–117 Occurrence Handle1:CAS:528:DyaK1MXlvVOhs7o%3D Occurrence Handle10460064
PK Janicki MF James WA Erskine (1992) ArticleTitlePropofol inhibits enzymatic degradation of alfentanil and sufentanil by isolated liver microsomes in vitro Br J Anaesth 68 311–312 Occurrence Handle1:CAS:528:DyaK38XitVOgt70%3D Occurrence Handle1532122
A Gottschalk M Freitag MA Burmeister C Becker EP Ernst-Peter Horn T Standl (2002) ArticleTitlePatient-controlled thoracic epidural infusion with ropivacaine 0.375% provides comparable pain relief as bupivacaine 0.125% plus sufentanil after major abdominal gynecologic tumor surgery Reg Anesth Pain Med 27 367–373 Occurrence Handle10.1053/rapm.2002.32583 Occurrence Handle1:CAS:528:DC%2BD38XmsVGrsrs%3D Occurrence Handle12132060
B Korman RH Riley (1997) ArticleTitleConvulsions induced by ropivacaine during interscalene brachial plexus block Anesth Analg 85 1128–1129 Occurrence Handle1:STN:280:DyaK1c%2Fhs1Wqsg%3D%3D Occurrence Handle9356113
E Arlander G Ekstrom C Alm JA Carrillo M Bielenstein Y Bottiger L Bertilsson LL Gustafsson (1998) ArticleTitleMetabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitors Clin Pharmacol Ther 64 484–491 Occurrence Handle10.1016/S0009-9236(98)90131-X Occurrence Handle1:CAS:528:DyaK1cXnvFSit7o%3D Occurrence Handle9834040
S Inomata A Nagashima Y Osaka T Kazama E Tanaka S Sato H Toyooka (2003) ArticleTitlePropofol inhibits lidocaine metabolism in human and rat liver microsomes J Anesth 17 246–250 Occurrence Handle14625712
R Regenthal M Krueger C Koeppel R Preiss (1999) ArticleTitleDrug levels: therapeutic and toxic serum plasma concentrations of common drugs J Clin Monit Comput 15 529–544 Occurrence Handle1:STN:280:DC%2BD3s%2FmslClsg%3D%3D
M Schulz A Schmoldt (2003) ArticleTitleTherapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics Pharmazie 58 447–474 Occurrence Handle1:CAS:528:DC%2BD3sXlsVOjs7w%3D Occurrence Handle12889529
PS Sebel JD Lowdon (1989) ArticleTitlePropofol: a new intravenous anesthetic Anesthesiology 71 260–277 Occurrence Handle1:CAS:528:DyaL1MXltVygtLc%3D Occurrence Handle2667401
MH Court SX Duan LM Hesse K Venkatakrishnan DJ Greenblatt (2001) ArticleTitleCytochrome P450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes Anesthesiology 94 110–119 Occurrence Handle1:CAS:528:DC%2BD3MXmsFKjtQ%3D%3D Occurrence Handle11135730
Y Oda N Hamaoka T Hiroi S Imaoka I Hase K Tanaka Y Funae T Ishizaki A Asada (2001) ArticleTitleInvolvement of human liver cytochrome P4502B6 in the metabolism of propofol Br J Clin Pharmacol 51 281–285 Occurrence Handle10.1046/j.1365-2125.2001.00344.x Occurrence Handle1:CAS:528:DC%2BD3MXivVOntbk%3D Occurrence Handle11298076
Y Oda K Furuichi K Tanaka T Hiroi S Imaoka A Asada M Fujimori Y Funae (1995) ArticleTitleMetabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450 Anesthesiology 82 214–220 Occurrence Handle1:CAS:528:DyaK2MXltlCnur8%3D Occurrence Handle7832304
G Ekström UB Gunnarsson (1996) ArticleTitleRopivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes Drug Metab Dispos 24 955–961 Occurrence Handle8886604
MJ Jokinen J Ahonen PJ Neuvonen KT Olkkola (2000) ArticleTitleThe effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine Anesth Analg 91 1207–1212 Occurrence Handle1:CAS:528:DC%2BD3cXot1Sluro%3D Occurrence Handle11049910
MJ Jokinen KT Olkkola J Ahonen PJ Neuvonen (2001) ArticleTitleEffect of ciprofloxacin on the pharmacokinetics of ropivacaine Eur J Clin Pharmacol 58 653–657
MJ Jokinen J Ahonen PJ Neuvonen KT Olkkola (2001) ArticleTitleEffect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine Pharmacol Toxicol 88 187–191 Occurrence Handle10.1034/j.1600-0773.2001.d01-102.x Occurrence Handle1:CAS:528:DC%2BD3MXjtVahur0%3D Occurrence Handle11322176
E Tanaka Y Takano S Inomata H Toyooka K Honda (2004) ArticleTitlePremedication medicines do not cause drug metabolic interaction with propofol using human liver microsomes in vitro Eur J Clin Pharmacol 60 565–568 Occurrence Handle10.1007/s00228-004-0807-3 Occurrence Handle15351923
D Wiedemann B Mühlnickel E Staroske W Neumann W Röse (2000) ArticleTitleRopivacaine plasma concentrations during 120-hour epidural infusion Br J Anaesth 85 830–835 Occurrence Handle10.1093/bja/85.6.830 Occurrence Handle1:CAS:528:DC%2BD3cXptVeisrY%3D Occurrence Handle11732514
P Pere M Salonen M Jokinen PH Rosenberg PJ Neuvonen J Haasio (2003) ArticleTitlePharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block Anesth Analg 96 563–569 Occurrence Handle1:CAS:528:DC%2BD3sXhsFyhurg%3D Occurrence Handle12538213
Author information
Authors and Affiliations
About this article
Cite this article
Osaka, Y., Inomata, S., Tanaka, E. et al. Effect of propofol on ropivacaine metabolism in human liver microsomes. J Anesth 20, 60–63 (2006). https://doi.org/10.1007/s00540-005-0358-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00540-005-0358-5